Cargando…
Everolimus for pediatric patients with acute graft-versus-host disease after hematopoietic stem cell transplantation: A pilot study
Acute graft-versus-host disease (aGVHD) is a significant cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). Due to the poor prognosis for patients not responding to first-line steroids treatment, improvements in aGVHD therapy are needed. Everolimus is a...
Autores principales: | Chao, Yu-Hua, Chang, Yin-Chen, Wu, Han-Ping, Peng, Ching-Tien, Weng, Te-Fu, Wu, Kang-Hsi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682816/ https://www.ncbi.nlm.nih.gov/pubmed/29095297 http://dx.doi.org/10.1097/MD.0000000000008464 |
Ejemplares similares
-
Giardia lamblia mimicking acute graft versus host disease after allogeneic hematopoietic stem cell transplantation: A case report
por: Ma, Shengling, et al.
Publicado: (2020) -
Outcomes of high-grade gastrointestinal graft-versus-host disease posthematopoietic stem cell transplantation in children
por: Uygun, Vedat, et al.
Publicado: (2016) -
Treatment of intestinal graft-versus-host disease with unrelated donor fecal microbiota transplantation capsules: A case report
por: Mao, Dan, et al.
Publicado: (2020) -
Successful Treatment of Fibrosing Cholestatic Hepatitis Following Kidney Transplantation With Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report
por: Li, Dong Liang, et al.
Publicado: (2015) -
Allogeneic hematopoietic stem cell transplantation in a patient with HIV-negative recurrent plasmablastic lymphoma: A case report
por: Rong, Chunmeng, et al.
Publicado: (2021)